Compound medicament for treating synovitis

Abstract

The invention discloses a combined drug for treating synovitis, including an oral drug and an external application drug. The part rate of the oral drug is that Rhizoma Atractylodis 10-20 parts, Cortex Phellodendri 10-20 parts, Radix Stephaniae Tetrandrae 10-20 parts, Chaenomeles sinensis 10-20 parts, Harms Manyprickle Acanthopanax 10-20 parts, Radix Clematidis Chinensis 10-20 parts, Radix Angelicae Pubescentis 10-20 parts, Radix Paeoniae Alba 10-20 parts, Radix Astragali 30-60 parts, Semen Coicis 30-60 parts, Radix Codonopsis 30-60 parts, Radix Angelicae Dahuricae 8-15 parts and Ramulus Cinnamomi 8-15 parts. The part rate of the external application drug is that Radix Aconiti Kusnezoffii 2-20 parts, Radix Aconiti, 5-10 parts, Rhizoma et Radix Notopterygii 5-20 parts, Flos Carthami 5-10 parts, Radix Saposhnikoviae 10-20 parts, Ramulus Cinnamomi 5-10 parts, Ramulus Mori 2-5 parts, Rhizoma Atractylodis 5-10 parts, Radix Aconiti Lateralis Preparata 10-20 parts, Herba Epimedii 5-10 parts, Caulis Impatientis 10-20 parts, Radix Angelicae Pubescentis 10-20 parts, Radix Angelicae Dahuricae 10-20 parts and Herba Asari 10-20 parts. The combined drug of the invention achieves the potency of drug to be directly delivered to the focus through oral taking, local suffocating and foment and realizes good treatment effect.

Description

technical field [0001] The present invention relates to a medical preparation containing raw materials derived from plants, in particular to a combination medicine for treating synovitis. Background technique [0002] Rheumatoid arthritis is a chronic systemic immune disease characterized by joint synovitis. Small joints such as hands, fingers, and toes are most likely to be involved, with persistent and repeated attacks. In the early stage, the joints are red, swollen, hot, painful and dysfunctional, and in the late stage, the joints are ankylized or deformed, and even disabled. [0003] Rheumatoid arthritis is a very complex disease, and its pathogenesis is multifaceted. So far, the etiology of rheumatoid arthritis has not been fully elucidated. Rheumatoid arthritis is characterized by chronic synovitis. Characteristic, autoimmune disease that culminates in cartilage resorption, bone destruction, and bone fibrosis. The characteristic changes of synovial membrane in rheum...

AI Technical Summary

Problems solved by technology

[0009] In summary, there is no effective therapy for diseases such as synovitis and rheumatoid arthritis.